The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
Everyone may be talking about the death of movie theaters, but here are the sleeper hit movies you may have missed in '25, and five not to miss in '26.
California Pizza Kitchen enters a new era as fresh investment fuels growth, innovation, and global expansion—showing how legacy restaurant brands stay relevant.
Holiday shopping heats up as Tom’s Guide editor Kate Kozuch reveals the tech gifts everyone wants, from wellness gadgets to gaming buzz—and how to score deals!
